Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).

Bilici A., Olmez O. F., Sezer A., Oksuzoglu B., Kaplan M. A., Karadurmus N., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 3 - 07 June 2022, vol.40, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 40
  • Country: ELECTR NETWORK
  • Trakya University Affiliated: Yes